Researchers at Colorado State University say cannabidiol (CBD) could prove to be useful in tackling glioblastoma, an aggressive and often deadly form of brain cancer.According to the American Association of Neurological Surgeons, Glioblastoma multiforme (GBM) has an incidence of two to three per 100,000 adults per year, and accounts...

New South Wales based Medlab Clinical (ASX:MDC) says it achieved record sales of its NanaBis product in the first quarter of this year.NanaBis is a product containing 1:1 ratios of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), delivered in a sub-micron spray applied to the oro-buccal membrane; i.e. the inside of...

For Australians eager to more easily gain access to cannabidiol, the prospect of CBD without a prescription is edging closer to reality.Currently, cannabidiol is a Schedule 4 (S4) Prescription Only Medicine in Australia - and getting a script is only one hurdle to clear. Back in January, we mentioned...

A CAD $1.5 million grant has been awarded by the Canadian Institutes of Health Research’s Institute of Cancer Research and the Canadian Cancer Society to look into the use of medical cannabis in children with cancer.The study, called C4T (Canadian Childhood Cannabinoid Clinical Trials), will be led by the...

A new survey report has revealed a quarter of Australians with inflammatory bowel disease have used medicinal cannabis to ease their symptoms.Inflammatory bowel disease (IBD) is a term used to describe disorders involving chronic inflammation of the digestive tract. Types of IBD include ulcerative colitis and Crohn's disease. According...

Hemp-derived CBD company Elixinol Global (ASX: EXL) has announced a new CEO and non-Executive Director.Oliver Horn, who was formerly the CEO of Swisse Wellness and was earlier this month tapped to be an independent Non-Executive Director of Elixinol, is replacing Stratos Karousos as Elixinol Group CEO.It was also announced...

Researchers from the University at Buffalo and the University of Michigan have found consumer knowledge of cannabinoids and dosing is severely lacking - even among those you would assume would know.The researchers surveyed 500 frequent cannabis users at an marijuana advocacy event held on University of Michigan's campus. Questions...

Another study has indicated the cannabinoid cannabidiol (CBD) could have an important role to play in battling antibiotic-resistant bacteria.Overuse of antibiotics is the main cause of antibiotic resistance, but misuse also plays a role - for example, not completing a course of antibiotics. The health sector is  facing a...

Australia Primary Hemp Limited (ASX:APH) published its quarterly report last week - and the market indicated things were looking pretty good.The company kicked off in August 2016 and today handles everything from seed selection, cultivation and processing to packaging under contract, bulk and retail sales. Its products are made...

Western Australia's Little Green Pharma (ASX:LGP) has achieved what it says is another Australian first - exporting medical cannabis products destined for use by patients in the UK.Little Green Pharma says the products are to be distributed in the UK by Astral Health and were part of a purchase...